Velzatinib (IDRX-42, GSK6042981)
StrateGIST 1
GSK · Phase 1 · Active, not recruiting · Enrollment 276
| Arm | Reported safety |
|---|---|
| Velzatinib 300 mg tablet (or 400 mg capsule), 2L | n/r |
| Velzatinib, 1L | n/r |
A count stays a count. This page does not turn a count into a percent.